Sentences with phrase «cancer immunobiology»

Medical Director, ONJCRI Head, Cancer Immunobiology Laboratory Medical Director, Cancer and Neurosciences, Clinical Services Unit, Austin Health

Dr Katherine Woods is a Postdoctoral Research Fellow working in the Cancer Immunobiology Laboratory.

Not exact matches

Caetano Reis e Sousa, head of the immunobiology lab at Cancer Research UK's London Research Institute, sounds says the work is «exciting» but cautions that it is at an early stage.

Department of Cell Biology and Section of Immunobiology, Ludwig Institute for Cancer Research, Yale University School of Medicine, 333 Cedar Street, Post Office Box 208002, New Haven, CT 06520 — 8002, USA.

We are particularly interested in leverage our interdisciplinary expertise in polymer chemistry, nanomedicine, drug delivery and immunobiology to innovate new approaches to modulate the tumor microenvironment and enhance cellular immune responses to cancer vaccines.

Participating institutions: Helmholtz Association • CNRS • Institute of Molecular Biotechnology • Research Center for Molecular Medicine of the Austrian Academy of Sciences • VIB - KU Leuven • Friedrich Miescher Institute for Biomedical Research • University of Basel • University of Zurich • Central European Institute of Technology • Max Planck Institute of Immunobiology and Epigenetics • Max Planck Institute for Molecular Genetics • German Cancer Research Center • Max Delbrück Center for Molecular Medicine • German Center for Neurodegenerative Diseases • Helmholtz Zentrum München • Max Planck Institute for Evolutionary Anthropology • Helmholtz Institute of RNA - based Infection Research • Saarland University • Technical University Munich • University of Würzburg • Biotech Research & Innovation Centre • Interdisciplinary Nanoscience Center • University of Copenhagen • Centre for Genomic Regulation • Institut Curie • Université de Montpellier • Inserm • Université Toulouse III — Paul Sabatier • École nationale supérieure des mines de Paris • Institute for Molecular Medicine Finland • The Biomedical Research Foundation, Academy of Athens • Weizmann Institute of Science • Hebrew University • Sapienza — University of Rome • Instituto Nazionale Genetica Molecolare • University of Napoli • University of Padua • University of Milan • European Institute of Oncology • Netherlands Cancer Institute • Radboud University • University Medical Center Utrecht • Hubrecht Institute • Instituto Gulbenkian de Ciência • Institute of Bioorganic Chemistry of the Polish Academy of Sciences • Romanian Center for Systems Immunology • Karolinska Institute • MRC Human Genetics Unit • University of Edinburgh • Wellcome Sanger Institute • The Babraham Institute • European Molecular Biology Laboratory — European Bioinformatics Institute

That first breakthrough continues to inform the work of Dr. Medzhitov, who is today the David W. Wallace Professor of Immunobiology at Yale University Medical School, a member of Yale Cancer Center and the National Academy of Sciences, and an HHMI investigator.

We thank D.L. Court (National Cancer Institute) for plasmid pSIM18 for the generation of BAC - transgenic mice; J.G. Cyster (UC San Francisco) for Hy10 mice; E. Hobeika and M. Reth (Max Planck Institute of Immunobiology and Epigenetics) for Mb1 - Cre mice; M. Nussenzweig (The Rockefeller University) for B1 - 8hi mice, anti-DEC205 — OVA and anti-DEC205 — CS; G.D. Victora (Whitehead Institute for Biomedical Research) for gene sets for the gene - set - enrichment analysis; O. Ohara, T. Watanabe and Y. Mochizuki for transcriptome analysis; W. Ise for discussions; M. Tochigi, C. Kawai, A. Arakawa and H. Masuda for technical assistance; P. Burrows for critical reading; and R. Brink for communicating unpublished results.

United Technologies Corporation professor in Cancer Research and professor of immunobiology, of dermatology and of medicine, Yale University

Professor of Microbiology & Immunobiology, Harvard Medical School Chair & Professor; Department of Cancer Immunology & Virology, Dana - Farber Cancer Institute

This research will have a significant impact on understanding neoantigen - T cell immunobiology and could improve the treatment prospects of pancreatic cancer patients.

Dr. Lieping Chen currently serves as the United Technologies Corporation Professor in Cancer Research, Professor of Immunobiology, Dermatology and Medical Oncology at Yale School of Medicine and co-Director of the Cancer Immunology Program of Yale Cancer Center in New Haven, CT..

James Allison, professor of immunology and chair of the Department of Immunology, The University of Texas MD Anderson Cancer Center Lieping Chen, United Technologies Corporation Professor in Cancer Research and professor of immunobiology, of dermatology and of medicine, Yale University Gordon Freeman, professor of medicine, Dana - Farber Cancer Institute, Harvard Medical School Tasuku Honjo, professor of immunology and genomic medicine, Kyoto University Arlene Sharpe, the George Fabyan Professor of Comparative Pathology, Harvard Medical School; senior scientist, department of pathology, Brigham and Women's Hospital

By integrating the aforementioned observations of FMc in autoimmunity and transplantation immunobiology, we reasoned that allogeneic FMc might provide immune surveillance for breast cancer in parous women.

Funding: This work was supported by the Alliance for Cancer Gene Therapy (R.H.V.), the Onyx and Breezy Foundation (K.U.S.), the Barry and Savannah Poodle Memorial Fund and the Mari Lowe Comparative Oncology Center (N.J.M.), the Immunobiology Program of the Abramson Cancer Center at the University of Pennsylvania (NIH grant P30 CA016520, R.H.V.), and the Oncology Research fund at the Veterinary Hospital of the University of Pennsylvania (K.U.S.).